Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review

scientific article published on 28 February 2008

Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1021/PR800115F
P698PubMed publication ID18303834

P50authorOle N JensenQ37830619
Werner VachQ38803024
Jonna S MadsenQ64147320
P2093author name stringTorben A Kruse
Ole Mogensen
Søren Cold
Per E Jørgensen
Anne K Callesen
P433issue4
P921main subjectreproducibilityQ1425625
systematic reviewQ1504425
diagnosisQ16644043
P304page(s)1395-1402
P577publication date2008-02-28
P1433published inJournal of Proteome ResearchQ3186939
P1476titleReproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review
P478volume7

Reverse relations

cites work (P2860)
Q33862872Breast cancer proteomics: a review for clinicians
Q37525625Challenges, current status and future perspectives of proteomics in improving understanding, diagnosis and treatment of vascular disease.
Q37234005Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care.
Q33885885Clinical proteomics of breast cancer
Q33454967Do serum biomarkers really measure breast cancer?
Q45887105Freeze-dried plasma proteins are stable at room temperature for at least 1 year.
Q33577268Imaging and 'omic' methods for the molecular diagnosis of cancer
Q34327104Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures
Q30401624Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
Q37484011Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
Q30985472Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.
Q33481276Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer
Q34160509PPINGUIN: Peptide Profiling Guided Identification of Proteins improves quantitation of iTRAQ ratios
Q64235676Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt
Q30432789Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients
Q33599591Protein mass spectra data analysis for clinical biomarker discovery: a global review
Q34669870Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
Q37405931Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers
Q34395996Proteomic serum biomarkers and their potential application in cancer screening programs
Q34319634Proteomic studies in breast cancer (Review).
Q34160919Purification, identification and profiling of serum amyloid A proteins from sera of advanced-stage cancer patients
Q33602325Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling
Q47165512Random and independent sampling of endogenous tryptic peptides from normal human EDTA plasma by liquid chromatography micro electrospray ionization and tandem mass spectrometry.
Q34056239Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms
Q34477298Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach
Q47158443The proteins cleaved by endogenous tryptic proteases in normal EDTA plasma by C18 collection of peptides for liquid chromatography micro electrospray ionization and tandem mass spectrometry
Q59670812Ultrahigh resolution profiles lead to more detailed serum peptidome signatures of pancreatic cancer
Q33891886Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer research.

Search more.